Compare Target Corporation (TGT) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Target Corporation vs Twist Bioscience Corp — how do they compare? Target Corporation trades at $138.64 (market cap $63.40B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Target Corporation is far larger — about 11.6× Twist Bioscience Corp's market cap, and Target Corporation pays a 3.32% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| TGT | TWST | |
|---|---|---|
Market Cap | $63.40B | $5.45B |
Sector | Consumer Cyclical | Health |
52-Week High | $141.19 | $102.88 |
52-Week Low | $83.68 | $24.16 |
Enterprise Value | $78.70B | $5.37B |
Dividend Yield | 3.32% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Target Corporation
With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
